Tashinga E. Bapiro
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 15
- Pancreatic and Hepatic Oncology Research 10
- Drug Transport and Resistance Mechanisms 4
- Cancer Cells and Metastasis 3
-
- Pharmacogenetics and Drug Metabolism 9
- Co-authors
- Duncan I. Jodrell (12 shared papers)David A. Tuveson (8 shared papers)Albrecht Neeße (6 shared papers)Kristopher K. Frese (6 shared papers)Natalie Cook (5 shared papers)Martijn P. Lolkema (2 shared papers)Frances M. Richards (8 shared papers)Tomoaki Nakagawa (2 shared papers)
- Journals
- Gut (3 papers)European Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)Cancer Discovery (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesZimbabwe
In The Last Decade
Tashinga E. Bapiro
21 papers receiving 2.2k citations
Tashinga E. Bapiro's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.6k
- Cancer Research 500
- Pharmacology 163
- Immunology 380
- Biotechnology 126
Countries citing papers authored by Tashinga E. Bapiro
This map shows the geographic impact of Tashinga E. Bapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tashinga E. Bapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tashinga E. Bapiro more than expected).
Fields of papers citing papers by Tashinga E. Bapiro
This network shows the impact of papers produced by Tashinga E. Bapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tashinga E. Bapiro. The network helps show where Tashinga E. Bapiro may publish in the future.
Co-authors
The 25 scholars most cited alongside Tashinga E. Bapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer Hit paper breakdown → | 2012 | 837 |
| 2 | 2012 | 320 | |
| 3 | 2013 | 199 | |
| 4 | 2017 | 148 | |
| 5 | 2013 | 118 | |
| 6 | 2016 | 108 | |
| 7 | Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. | 2001 | 85 |
| 8 | 2012 | 74 | |
| 9 | 2016 | 64 | |
| 10 | 2011 | 47 | |
| 11 | 2019 | 41 | |
| 12 | 2002 | 34 | |
| 13 | 2005 | 32 | |
| 14 | 2013 | 32 | |
| 15 | 2018 | 28 | |
| 16 | 2012 | 28 | |
| 17 | 2002 | 24 | |
| 18 | 2018 | 16 | |
| 19 | 2004 | 15 | |
| 20 | 2023 | 6 |
About Tashinga E. Bapiro
Tashinga E. Bapiro is a scholar working on Oncology, Pharmacology, Molecular Biology, Cancer Research and Computational Theory and Mathematics, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers), Computational Drug Discovery Methods (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (500 citations), Pharmacology (163 citations), Immunology (380 citations) and Biotechnology (126 citations). Tashinga E. Bapiro has collaborated with scholars based in United Kingdom, United States and Zimbabwe. Frequent co-authors include Duncan I. Jodrell, David A. Tuveson, Albrecht Neeße, Kristopher K. Frese, Natalie Cook, Martijn P. Lolkema, Frances M. Richards, Tomoaki Nakagawa, Derek Chan and Michael A. Jacobetz. Their work appears in journals such as Gut, European Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Cancer Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.